Results
1 -
10 of
109Clinical experience of encainide (MJ 9067): A new anti-arrhythmic drug, European Journal of Clinical Pharmacology Class IC Antiarrhythmic Agents: Status ? 1984, Cardiac Arrhythmias: New Therapeutic Drugs and Devices Is There a Rational Basis for the Modified Classification of Antiarrhythmic Drugs?, Cardiac Arrhythmias: New Therapeutic Drugs and Devices Pharmacokinetic and Pharmacological Aspects of Polymorphic Drug Oxidation in Man, Pharmacokinetics Encainide, Cardiovascular Drug Therapy in the Elderly Application of Pharmacologic Principles in the Evaluation of New Antiarrhythmic Agents, Sudden Cardiac Death and Congestive Heart Failure: Diagnosis and Treatment Clinical Pharmacodynamics of Cardiovascular Agents: Focus on Sudden Cardiac Death, Integration of Pharmacokinetics, Pharmacodynamics, and Toxicokinetics in Rational Drug Development The Integration of Pharmacodynamics and Pharmacokinetics in Rational Drug Development, Integration of Pharmacokinetics, Pharmacodynamics, and Toxicokinetics in Rational Drug Development Sodium Channel-Blocking Antidysrhythmics, Critical Care Toxicology Combining Drugs with the Implantable Cardioverter Defibrillator: Clinical Implications, The Implantable Cardioverter/Defibrillator